Literature DB >> 18037815

Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia.

Kyeong-Sae Na1, Yong-Ku Kim.   

Abstract

A growing body of evidence suggests that changes in the serum levels and cellular production of various cytokines are associated with the immunological abnormalities of schizophrenia. Several studies have examined alterations in T helper type 1 (Th1) and T helper type 2 (Th2) cytokines in schizophrenia. We explored monocytic, Th1 and Th2 cytokines in 43 schizophrenia patients and 50 normal controls. The mitogen-induced production of tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), IL-4, gamma-interferon (IFN-gamma) and IL-2 was measured with enzyme-linked immunosorbent assays before and after antipsychotic treatment. IL-6 and TNF-alpha production by schizophrenic patients was significantly higher than by normal controls, while IL-2, IL-4 and IFN-gamma production was significantly lower in schizophrenic patients. After 6 weeks of antipsychotic treatment, IL-6 and TNF-alpha production was significantly decreased, while IL-4, IFN-gamma and IL-2 productions were not significantly changed. Our results suggest that increased monocytic cytokines and decreased Th1 and Th2 cytokines may be associated with the immunopathogenesis of acute psychotic schizophrenia, and that antipsychotics may play an important role in immune response by decreasing elevated monocytic cytokines. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037815     DOI: 10.1159/000111535

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  14 in total

1.  Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6.

Authors:  Daniela L Krause; Jenny K Wagner; Agnes Wildenauer; Judith Matz; Elif Weidinger; Michael Riedel; Michael Obermeier; Rudolf Gruber; Markus Schwarz; Norbert Müller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-01-21       Impact factor: 5.270

2.  Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia.

Authors:  Xueqin Song; Xiaoduo Fan; Xue Li; Wei Zhang; Jinsong Gao; Jingping Zhao; Amy Harrington; Douglas Ziedonis; Luxian Lv
Journal:  Psychopharmacology (Berl)       Date:  2013-12-14       Impact factor: 4.530

Review 3.  Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?

Authors:  Urs Meyer; Joram Feldon; Olaf Dammann
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

4.  In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulation.

Authors:  Ketan Marballi; Marlon P Quinones; Fabio Jimenez; Michael A Escamilla; Henriette Raventós; Maria Clara Soto-Bernardini; Seema S Ahuja; Consuelo Walss-Bass
Journal:  J Mol Med (Berl)       Date:  2010-07-13       Impact factor: 4.599

5.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

Review 6.  Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia.

Authors:  Monojit Debnath; Michael Berk
Journal:  Mol Neurobiol       Date:  2016-11-29       Impact factor: 5.590

7.  Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR).

Authors:  Oliver Freudenreich; Mark A Brockman; David C Henderson; A Eden Evins; Xiaoduo Fan; Jared P Walsh; Donald C Goff
Journal:  Psychiatry Res       Date:  2010-02-04       Impact factor: 3.222

8.  The biochemical womb of schizophrenia: A review.

Authors:  N Gaur; S Gautam; M Gaur; P Sharma; G Dadheech; S Mishra
Journal:  Indian J Clin Biochem       Date:  2008-12-20

9.  Serum and gene expression profile of cytokines in first-episode psychosis.

Authors:  Marco Di Nicola; Annamaria Cattaneo; Nilay Hepgul; Marta Di Forti; Katherine J Aitchison; Luigi Janiri; Robin M Murray; Paola Dazzan; Carmine M Pariante; Valeria Mondelli
Journal:  Brain Behav Immun       Date:  2012-06-28       Impact factor: 7.217

10.  Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophrenia.

Authors:  Dorota Frydecka; Blazej Misiak; Jan Aleksander Beszlej; Lidia Karabon; Edyta Pawlak-Adamska; Anna Tomkiewicz; Anna Partyka; Anna Jonkisz; Andrzej Kiejna
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.